# Preeclampsia and Fetal Heart Malformations: Looking to Maternal Heart

Study · id `cardio:ct-nct07092644` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07092644](<https://clinicaltrials.gov/study/NCT07092644>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07092644

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 108 participants.

## Technical summary

Registry record NCT07092644. Allocation not applicable; no masking; primary purpose other. Start 2023-11-16 (actual); primary completion 2026-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 108 participants (planned count; ClinicalTrials.gov record NCT07092644, source copy `cardio:ctgov-nct07092644-2025-07-30`, retrieved 2026-10-26)
- Started: 2023-11-16 (actual) (ClinicalTrials.gov record NCT07092644, source copy `cardio:ctgov-nct07092644-2025-07-30`, retrieved 2026-10-26)
- Primary completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT07092644, source copy `cardio:ctgov-nct07092644-2025-07-30`, retrieved 2026-10-26)
- Completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT07092644, source copy `cardio:ctgov-nct07092644-2025-07-30`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT07092644, source copy `cardio:ctgov-nct07092644-2025-07-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07092644-2025-07-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Preeclampsia and Fetal Heart Malformations: Looking to Maternal Heart
- Acronym: MAMAH
- Condition: Congenital Heart Disease
- Intervention (Device): UltraSonic Cardiac Output Monitor (USCOM®)
- Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS (`cardio:org-fondazione-policlinico-universitario-agostino-gemelli-irccs`)

## Provenance

Content hash: f16f18e7fd28da1cbc422deedb7d3ff481ffdbae909c91f671b42b620c5140e1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
